• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含有 CD38、CD49d、CD44 和 MMP-9 的不良预后 CLL 中的大分子复合物的证据。

Evidence for a macromolecular complex in poor prognosis CLL that contains CD38, CD49d, CD44 and MMP-9.

机构信息

Department of Haematological Medicine, King's College London, London, UK.

出版信息

Br J Haematol. 2011 Jul;154(2):216-22. doi: 10.1111/j.1365-2141.2011.08725.x. Epub 2011 May 14.

DOI:10.1111/j.1365-2141.2011.08725.x
PMID:21569005
Abstract

Progressive chronic lymphocytic leukaemia is characterized by the accumulation of neoplastic B-cells in the tissues and correlates with the expression of prognostic biomarkers, such as CD38, CD49d and matrix metalloproteinase-9 (MMP9), which are involved in migration and tissue invasion. In this study we investigated the physical relationship between these molecules and demonstrated that CD38, CD49d, MMP9 and CD44 were physically associated in a supramolecular cell surface complex. Our findings provide a molecular basis for the correlation between expression of these proteins and prognosis and, as the complex is not present in normal B-cells, suggest a novel leukaemia-specific therapeutic target.

摘要

进行性慢性淋巴细胞白血病的特征是肿瘤 B 细胞在组织中的积累,并与预后生物标志物的表达相关,如 CD38、CD49d 和基质金属蛋白酶-9(MMP9),这些标志物参与迁移和组织侵袭。在这项研究中,我们研究了这些分子之间的物理关系,并证明 CD38、CD49d、MMP9 和 CD44 在一个超分子细胞表面复合物中物理相关。我们的发现为这些蛋白的表达与预后之间的相关性提供了分子基础,并且由于该复合物不存在于正常 B 细胞中,因此提示了一个新的白血病特异性治疗靶点。

相似文献

1
Evidence for a macromolecular complex in poor prognosis CLL that contains CD38, CD49d, CD44 and MMP-9.含有 CD38、CD49d、CD44 和 MMP-9 的不良预后 CLL 中的大分子复合物的证据。
Br J Haematol. 2011 Jul;154(2):216-22. doi: 10.1111/j.1365-2141.2011.08725.x. Epub 2011 May 14.
2
CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival.CD38/CD31、CCL3和CCL4趋化因子以及CD49d/血管细胞黏附分子-1通过维持慢性淋巴细胞白血病细胞存活的一系列连续事件相互关联。
Cancer Res. 2009 May 1;69(9):4001-9. doi: 10.1158/0008-5472.CAN-08-4173. Epub 2009 Apr 21.
3
The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells.CD49d/CD29 复合物在物理和功能上与 B 细胞慢性淋巴细胞白血病细胞中的 CD38 相关联。
Leukemia. 2012 Jun;26(6):1301-12. doi: 10.1038/leu.2011.369. Epub 2012 Jan 6.
4
CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia.CD49d表达是早期慢性淋巴细胞白血病疾病进展的独立危险因素。
Haematologica. 2008 Oct;93(10):1575-9. doi: 10.3324/haematol.13103. Epub 2008 Jul 18.
5
High CD49d protein and mRNA expression predicts poor outcome in chronic lymphocytic leukemia.高CD49d蛋白和mRNA表达预示慢性淋巴细胞白血病预后不良。
Clin Immunol. 2009 Jun;131(3):472-80. doi: 10.1016/j.clim.2009.02.004. Epub 2009 Mar 24.
6
HLA-G expression as a prognostic indicator in B-cell chronic lymphocytic leukemia.HLA - G表达作为B细胞慢性淋巴细胞白血病的预后指标
Acta Haematol. 2014;132(1):53-8. doi: 10.1159/000353757. Epub 2014 Feb 15.
7
CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential.CD49d表达是慢性淋巴细胞白血病患者总生存期的独立预测指标:一个具有治疗潜力的预后参数。
Br J Haematol. 2008 Mar;140(5):537-46. doi: 10.1111/j.1365-2141.2007.06965.x.
8
The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia.慢性淋巴细胞白血病中预后标志物 CD38 和 CD49d 的致病相关性。
Ann Hematol. 2014 Mar;93(3):361-74. doi: 10.1007/s00277-013-1967-y. Epub 2013 Nov 28.
9
The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience.诊断时前瞻性研究慢性淋巴细胞白血病患者中CD38表达的预后价值:单机构经验
Br J Haematol. 2005 Aug;130(4):549-57. doi: 10.1111/j.1365-2141.2005.05659.x.
10
Surface-antigen expression profiling (SEP) in B-cell chronic lymphocytic leukemia (B-CLL): Identification of markers with prognostic relevance.B细胞慢性淋巴细胞白血病(B-CLL)中的表面抗原表达谱分析(SEP):具有预后相关性标志物的鉴定。
J Immunol Methods. 2005 Oct 20;305(1):20-32. doi: 10.1016/j.jim.2005.07.004. Epub 2005 Aug 8.

引用本文的文献

1
CD44 Participates to Extramedullary Haematopoiesis Onset by Mediating the Interplay Between Monocytes and Haematopoietic Stem Cells in Myelofibrosis.CD44通过介导骨髓纤维化中单核细胞与造血干细胞之间的相互作用参与髓外造血的起始。
J Cell Mol Med. 2025 Jul;29(14):e70720. doi: 10.1111/jcmm.70720.
2
Establishment of a Basement Membrane-Related Prognosis Model and Characterization of Tumor Microenvironment Infiltration in Acute Myeloid Leukemia.急性髓系白血病中基底膜相关预后模型的建立及肿瘤微环境浸润特征分析
J Cancer. 2025 Jan 13;16(4):1228-1242. doi: 10.7150/jca.108041. eCollection 2025.
3
CD44: a cancer stem cell marker and therapeutic target in leukemia treatment.
CD44:白血病治疗中的癌症干细胞标志物和治疗靶点。
Front Immunol. 2024 Apr 26;15:1354992. doi: 10.3389/fimmu.2024.1354992. eCollection 2024.
4
The Role of the Microenvironment and Cell Adhesion Molecules in Chronic Lymphocytic Leukemia.微环境和细胞粘附分子在慢性淋巴细胞白血病中的作用
Cancers (Basel). 2023 Oct 26;15(21):5160. doi: 10.3390/cancers15215160.
5
Flow Cytometric Expression of CD49d in Newly Diagnosed Chronic Lymphocytic Leukemia and Its Correlation with Established Prognostic Markers.流式细胞术检测新诊断慢性淋巴细胞白血病中CD49d的表达及其与既定预后标志物的相关性
J Lab Physicians. 2022 Jun 10;14(4):435-442. doi: 10.1055/s-0042-1748828. eCollection 2022 Dec.
6
TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target.TLR9 在慢性淋巴细胞白血病中的表达鉴定出一个促迁移亚群和新的治疗靶点。
Blood. 2021 Jun 3;137(22):3064-3078. doi: 10.1182/blood.2020005964.
7
Matrix Metalloproteinase-2 Single Nucleotide Polymorphism in Egyptian Non-Hodgkin Lymphoma Patients: Correlation with Clinicopathological Characteristics and Outcome.埃及非霍奇金淋巴瘤患者基质金属蛋白酶-2单核苷酸多态性:与临床病理特征及预后的相关性
Indian J Hematol Blood Transfus. 2019 Jul;35(3):471-477. doi: 10.1007/s12288-018-1056-4. Epub 2018 Dec 7.
8
α4β1 integrin associates with VEGFR2 in CLL cells and contributes to VEGF binding and intracellular signaling.α4β1 整合素在 CLL 细胞中与 VEGFR2 结合,并有助于 VEGF 结合和细胞内信号转导。
Blood Adv. 2019 Jul 23;3(14):2144-2148. doi: 10.1182/bloodadvances.2019000019.
9
Molecular Players in Hematologic Tumor Cell Trafficking.血液肿瘤细胞迁移中的分子参与者。
Front Immunol. 2019 Feb 6;10:156. doi: 10.3389/fimmu.2019.00156. eCollection 2019.
10
CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression.CD44/CD44v6:癌症起始细胞维持和肿瘤进展中的可靠“伙伴”
Front Cell Dev Biol. 2018 Aug 28;6:97. doi: 10.3389/fcell.2018.00097. eCollection 2018.